Smart Vision Labs closes $6.1M in Series A financing for mobile ophthalmic device

June 23, 2015

Smart Vision Labs has closed a $6.1M financing round for its SVOne smartphone-based ophthalmic device.

Smart Vision Labs (New York, NY) has closed a $6.1M Series A round to help commercialize its SVOne smartphone-based ophthalmic device that performs accurate, fast mobile vision exams wherever needed.

The SVOne autorefractor device uses wavefront aberrometry (an advanced technology used to characterize vision imperfection before performing corrective vision surgery) to measure a patient's refractive errors. The company is working with healthcare professionals to enable affordable, convenient, and high-quality access to vision care both domestically and abroad. To date, the device has been used to provide vision exams in clinics and mobile screenings in 21 different countries.

The company will use the Series A funding—which was led by Techstars Ventures and includes investments from Heritage Group, Connectivity Capital, and Red Sea Ventures—to further scale production of the device, develop additional products and services, and expand the team.

For more information, please visit www.smartvisionlabs.com.

Follow us on Twitter, 'like' us on Facebook, connect with us on Google+, and join our group on LinkedIn

About the Author

BioOptics World Editors

We edited the content of this article, which was contributed by outside sources, to fit our style and substance requirements. (Editor’s Note: BioOptics World has folded as a brand and is now part of Laser Focus World, effective in 2022.)